AstraZeneca COVID-19 vaccine information and FAQs

This page contains documents relating specifically to the AstraZeneca COVID-19 vaccine

National protocol for COVID-19 vaccine AstraZeneca

 

AstraZeneca and blood clot information

MHRA issues new advice, concluding a possible link between COVID-19 vaccine AstraZeneca and extremely rare, unlikely to occur blood clots

Public Health England COVID-19 vaccination and blood clotting

Letter update from the Medicines and Healthcare product Regulatory Agency (MHRA) and the independent Joint Committee on Vaccination and Immunisation (JCVI) guidance in relation to the use of the AstraZeneca vaccine

FAQ: MHRA and JCVI guidance on AstraZeneca COVID-19 vaccine and very rare clotting disorders

All suspected cases report to both the MHRA on the COVID-19 Yellow Card scheme and to PHE’s clinical reporting scheme at https://cutt.ly/haem_AE


AstraZeneca COVID-19 vaccine

Gov.uk - Regulatory approval of COVID-19 AstraZeneca vaccine

Regulatory approval of COVID-19 AstraZeneca vaccine

Patient Group Direction for COVID-19 AstraZeneca vaccine

Patient Group Direction for COVID-19 AstraZeneca vaccine

Individual assessment to assist the creation of Patient Specific Direction

Individual assessment to assist the creation of Patient Specific Direction for the administration of COVID-19 AstraZeneca vaccine

AstraZeneca Vaccine Ingredients

AstraZeneca Vaccine Ingredients

Position Statement - use of AstraZeneca to vaccinate housebound patients

Position statement around the use of COVID-19 vaccine AstraZeneca to vaccinate housebound patients

Patient Information Leaflet

Patient Information Leaflet for COVID-19 vaccine AstraZeneca

Summary of Product Characteristics

Summary of Product Characteristics for COVID-19 vaccine AstraZeneca

Support channels for healthcare professionals and recipients of the vaccine

Website - www.azcovid-19.com

Telephone - 0800 054 1028

England: For any questions in relation to the supply of COVID-19 vaccines, please contact

england.spocskh@nhs.net and england.covidvaccs@nhs.net

SPS FAQ information

SPS overall FAQ section related specifically to AstraZeneca vaccine

SPS answers to questions related specifically to AstraZeneca vaccine

Administration

SPS Administration AstraZeneca vaccine

Preparing and administering the AstraZeneca COVID-19 Vaccine

Institutional Readiness for Management of AstraZeneca COVID-19 Vaccine in Trusts                

Dealing with spillages and breakages of the AstraZeneca COVID-19 Vaccine at PCN sites

Cautions and contraindications

SPS Cautions and contraindications AstraZeneca vaccine

Advising individuals with allergies on their suitability for AstraZeneca COVID-19 Vaccine

Interactions information for AstraZeneca COVID-19 Vaccine

Contraindications and cautions summary for AstraZeneca COVID-19 Vaccine

Disposal

SPS Disposal AstraZeneca vaccine

Institutional Readiness for Management of AstraZeneca COVID-19 Vaccine in Trusts

Dealing with spillages and breakages of the AstraZeneca COVID-19 Vaccine at PCN site           

Disposing of AstraZeneca COVID-19 Vaccine at PCN designated sites

Dosing

SPS Dosing AstraZeneca vaccine

Dosing information for AstraZeneca COVID-19 Vaccine

Excipients

SPS Excipients AstraZeneca vaccine

Advising individuals with allergies on their suitability for AstraZeneca COVID-19 Vaccine

Advising individuals with religious or other dietary practices and beliefs on their suitability for the AstraZeneca COVID-19 Vaccine

Cold Chain

Institutional Readiness for Management of AstraZeneca COVID-19 Vaccine in Trusts

Receiving and storing the AstraZeneca COVID-19 Vaccine at PCN designated sites

Preparing

SPS Preparing AstraZeneca vaccine

Preparing the AstraZeneca COVID-19 Vaccine at PCN designated sites and end user locations

Institutional Readiness for Management of AstraZeneca COVID-19 Vaccine in Trusts

COVID-19 Vaccine AstraZeneca Handling and Preparation Video

Supply

SPS Supply AstraZeneca vaccine

Transporting the AstraZeneca COVID-19 Vaccine from PCN designated sites to end user locations and within the PCN Grouping

Institutional Readiness for Management of AstraZeneca COVID-19 Vaccine in Trusts

Stocktaking and reconciliation of the AstraZeneca COVID-19 Vaccine at PCN designated sites           

Ordering AstraZeneca COVID-19 Vaccine from Public Health England (PHE) for Trusts      

Receiving and storing the AstraZeneca COVID-19 Vaccine at PCN designated sites

Ordering the AstraZeneca COVID-19 Vaccine by PCN designated sites

 Community Pharmacy

 Using COVID-19 Vaccine AstraZeneca in Community Pharmacy


 

Derby and Derbyshire CCG

Derby and Derbyshire CCG

Please click the button to navigate to our app

Redirect to app